Psychopathy, Neuroscience, and the Law: A Primer for Courts and Policymakers

Psychopathy occupies a uniquely fraught space at the interface of science and law. It is routinely invoked in high-stakes decisions about culpability, dangerousness, sentencing, parole, and—more recently—organisational wrongdoing. Yet the construct is often imported into legal reasoning through confident narratives of “the psychopathic brain” or seemingly definitive test scores, masking the contested and methodologically fragile character of parts of the evidence base. This report provides an accessible, legally oriented primer on psychopathy, neuroscience, and their proper translation into court and policy settings. Drawing on contemporary debates in psychiatry and cognitive neuroscience, it synthesises five practical problem areas: (1) the unsettled state of neurobiological claims and the absence of a robust neural “signature” of psychopathy; (2) the implications of the replication crisis for expert reliance on striking single studies; (3) the strengths and limitations of psychopathy assessment instruments—especially the PCL-R—including cut-off arbitrariness, criminal-history weighting, cross-context transportability, and the risk of “adversarial allegiance”; (4) growing support for dimensional, trait-based accounts that sit uneasily with law’s binary categories; and (5) the expansion of psychopathy discourse into workplace and corporate contexts, where conceptual creep and rhetorical misuse are salient risks. The report argues for a cautious, transparent approach: psychopathy evidence can inform legal decision-making, but should be treated as fallible, contextualised, and triangulated rather than dispositive. It concludes by offering a pragmatic pathway for courts and policymakers to use psychopathy research without being used by it—favouring nuanced trait descriptions over stigmatic labels, and aligning scientific uncertainty with legal principles of fairness and proportionality.